Zingo
NDC Package 61388-123-48

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Zingo is an amide local anesthetic indicated for use on intact skin to provide local analgesia prior to venipuncture or peripheral intravenous cannulation in children 3–18 years of age. Marketed by Powder Pharmaceutical Incorporated, this product is identified by NDC 61388-123 and is authorized under FDA application NDA022114.

Identification & Billing

NDC Package Code
61388-123-48
Package Description
48 CARTON in 1 BOX / 12 POWDER in 1 CARTON (61388-123-12)
Product Code
61388-123
11-Digit Billing Format
61388012348

Clinical Specifications

Proprietary Name
Zingo
Dosage Form
-
Usage Information
ZINGO is an amide local anesthetic indicated for use on intact skin to provide local analgesia prior to venipuncture or peripheral intravenous cannulation in children 3–18 years of age. (1)ZINGO is indicated for use on intact skin to provide topical local analgesia prior to venipuncture in adults. (1)Important Limitations: For use on intact skin only (1, 2)For external use only (5)

Regulatory & Marketing

Labeler Name
Powder Pharmaceutical Incorporated
FDA Application #
NDA022114
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
11-01-2024
End Marketing Date
06-05-2026
Listing Expiration
06-05-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (61388-123). Click a package code to view its specific billing and regulatory data.

61388-123-26
12 POWDER in 1 POUCH

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61388-123-48 identifies a specific commercial package of 48 carton in 1 box / 12 powder in 1 carton (61388-123-12) of Zingo, labeled by Powder Pharmaceutical Incorporated. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Powder Pharmaceutical Incorporated on November 01, 2024. The current certification is valid through June 05, 2026.

How is this Powder Pharmaceutical Incorporated product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61388012348. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
61388-123-48
11-Digit CMS (5-4-2)
61388-0123-48

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.